Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Orthofix Medical (OFIX) Depreciation & Amortization (IS) (2018 - 2025)

Orthofix Medical (OFIX) has disclosed Depreciation & Amortization (IS) for 7 consecutive years, with $16.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Depreciation & Amortization (IS) changed N/A year-over-year to $16.9 million, compared with a TTM value of $47.0 million through Jun 2025, changed N/A, and an annual FY2023 reading of $53.1 million, up 82.86% over the prior year.
  • Depreciation & Amortization (IS) was $16.9 million for Q2 2025 at Orthofix Medical, up from $15.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $19.2 million in Q4 2021 and bottomed at $6.5 million in Q2 2022.
  • Average Depreciation & Amortization (IS) over 4 years is $10.2 million, with a median of $7.5 million recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (IS) soared 132.84% in 2021, then plummeted 61.35% in 2022.
  • Year by year, Depreciation & Amortization (IS) stood at $19.2 million in 2021, then tumbled by 61.35% to $7.4 million in 2022, then skyrocketed by 104.46% to $15.2 million in 2024, then grew by 11.19% to $16.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for OFIX at $16.9 million in Q2 2025, $15.2 million in Q3 2024, and $7.4 million in Q4 2022.